today show semaglutide In a new study, Ozempic-maker Novo Nordisk shows that its weight loss pill could achieve the similar efficacy as injectables. Novo Nordisk's Chief Scientific Officer says they're expecting FDA Hi everyone! 👋 There's still

Meet the requirements Very good product, it keeps you satisfied for a long time, you arrive at meals without anxiety, I'm on my second container and it works better every day, of course, you have to be consistent, the delivery is super fast and they are attentive to any time when your container is about to run out

Here is what each group received: 1mg group: 1mg weekly for the full 48 weeks, no escalation 4mg (starting at 2mg): Started at 2mg, escalated to 4mg after 4 weeks 4mg (starting at 4mg): Started directly at 4mg, no escalation 8mg (starting at 2mg): Started at 2mg, escalated through 4mg to reach 8mg 8mg (starting at 4mg): Started at 4mg, escalated to 8mg after 4 weeks 12mg (starting at 2mg): Started at 2mg, escalated through 4mg, 8mg to reach 12mg The weight loss results at 48 weeks told a clear story

The safety profile is favorable, with common side effects including mild to moderate gastrointestinal issues like nausea and diarrhea, and a low rate of discontinuation due to adverse events

Benvenga S, Ruggieri RM, Russo A, Lapa D, Campenni A, Trimarchi F